The EU Data Act: data versus trade secrets | Managing Intellectual Property
Wind power boom is fanning high-stakes international patent activity - Osborne Clarke | Osborne Clarke
Pharma industry watches as UK Court of Appeal considers issue of plausibility - Osborne Clarke | Osborne Clarke
LSPN Europe - 29th November, London
Tim Harris from Osborne Clarke outlines the role Arrow declarations can play in second medical use cases. All #LSPNLive sessions available on demand... | By World Intellectual Property Review | Facebook
2021 Life Sciences Patent Case Review - Osborne Clarke | Osborne Clarke
Osborne Clarke LLP > London > England | The Legal 500 law firm profiles
Tim Harris - Osborne Clarke | Osborne Clarke
Data-driven business models: the role of legal teams in delivering success | Report - Osborne Clarke | Osborne Clarke
Osborne Clarke posts 7% revenue growth and double-digit profit surge
Tim Harris from Osborne Clarke outlines the role Arrow declarations can play in second medical use cases. All #LSPNLive sessions available on demand... | By World Intellectual Property Review | Facebook
LSPN Europe - 29th November, London
Data-driven business models: the role of legal teams in delivering success | Report - Osborne Clarke | Osborne Clarke
Rewriting the 'patent bible': Judge Meade's first year in court | Managing Intellectual Property
Osborne Clarke strengthens biotech practice with Marks & Clerk hire - JUVE Patent
Bezahlung in Anwaltskanzleien – Was ist das beste Vergütungsmodell?
Energy Innovation Lawyers - Osborne Clarke
Global patent disputes shadow the rise of solar energy - Osborne Clarke | Osborne Clarke
Data-driven business models: the role of legal teams in delivering success | Osborne Clarke
Osborne Clarke reports 7% revenue hike to €341m as PEP rebounds - The Global Legal Post
Timely trials: are UK patent proceedings becoming easier to expedite? - Osborne Clarke | Osborne Clarke
Osborne Clarke on Twitter: "We're delighted to be sponsoring LSPN Live 2021! Join Tim Harris and Chris Pratt at 13:00 EDT (18:00 BST) today on their 'Strategies in Second Medical Use Cases'
Osborne Clarke wins Bird & Bird partner in London - JUVE Patent
